Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | G245D |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 G245D is a hotspot mutation that lies within the DNA binding domain of the Tp53 protein (PMID: 22713868). G245D results in decreased activation of Tp53 target genes (PMID: 22214764, PMID: 25634208, PMID: 27533082), and also confers a gain of function to Tp53 as demonstrated by aberrant interaction with ZBP-89, as well as induction of FOXM1 expression, and leads to decreased apoptosis in culture and increased tumor growth and metastasis in mouse models (PMID: 22214764, PMID: 29269868). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon7 TP53 G245D TP53 mutant TP53 inact mut TP53 G245D |
Transcript | NM_000546.6 |
gDNA | chr17:g.7674229C>T |
cDNA | c.734G>A |
Protein | p.G245D |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126113.2 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7674229C>T | c.734G>A | p.G245D | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|